JAYLA GREENE: Open Payments
NPI 1912413824 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,350 in 65 payments from 20 companies in 2025. Trend: 2023 $1,247 · 2024 $2,045 · 2025 $1,350
Food & beverage: $1,350
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $294 |
| CATALYST PHARMACEUTICALS, INC. | 7 | $170 |
| UCB, Inc. | 8 | $145 |
| CSL Behring | 5 | $106 |
| Eisai Inc. | 4 | $95 |
| Genentech USA, Inc. | 4 | $84 |
| Lilly USA, LLC | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
Products named: FYCOMPA, UBRELVY, Hizentra, Leqembi, Briviact, Ocrevus Zunovo, AMYVID, VYALEV.
Industry payments across KY — which companies pay providers there.
